Work

Initial testing (stage 1) of the BH3 mimetic ABT‐263 by the pediatric preclinical testing program

Year: 2007

Type: article

Source: Pediatric Blood & Cancer

DOI: 10.1002/pbc.21433

Authors: Richard Lock, Hernan Carol, Peter J. Houghton, Christopher L. Morton, E. Anders Kolb, Richard Gorlick, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Jianrong Wu, Malcolm A. Smith

Institutions: Children's Cancer Institute Australia, St. Jude Children's Research Hospital, Yeshiva University, Children's Hospital at Montefiore, University of Southern California, Children's Hospital Los Angeles, Children's Hospital of Philadelphia, University of Pennsylvania, Duke Medical Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1215897271, Pediatric Preclinical Testing Program, G1628177865, G3738888336, G609259107, SPORE in Brain Cancer, Cancer Center Support Grant (CCSG)

OpenAlex ID: W2087736211

FWCI: 5.558

Cites: 32

Cited by: 122

Related to: 10